Page last updated: 2024-10-30

meprobamate and Dystonic Disorders

meprobamate has been researched along with Dystonic Disorders in 1 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HAJEK, O1

Other Studies

1 other study available for meprobamate and Dystonic Disorders

ArticleYear
[Vegetative dystonia in gynecological practice and its control with Geneton].
    Therapie der Gegenwart, 1960, Volume: 99

    Topics: Autonomic Nervous System; Autonomic Nervous System Diseases; Dystonia; Dystonic Disorders; Humans; M

1960